Indaptus Therapeutics (INDP) Financials: Revenue & Earnings
INDP$3.33+0.03 +0.76%
$377.10M
Market Cap
—
P/E
—
Forward P/E
—
Score
Indaptus Therapeutics (INDP) Financials: Revenue & Earnings
INDP price $3.33 +0.03 +0.76%
- Ticker
- INDP
- Price
- $3.33
- Change
- +0.03 +0.76%
- Market cap ?
- $377.10M
- Beta ?
- 1.17
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
INDP fair value $30.88. Price $3.33. Price is 89% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-17 | — | -1.46 | — | — |
| 2026-08-13 | -0.02 | -0.02 | — | — |
| 2026-05-15 | -0.23 | -1.87 | — | — |
| 2026-03-17 | -3.10 | -4.36 | — | — |
| 2025-11-12 | -2.98 | -4.17 | — | — |
| 2025-08-11 | -9.09 | -10.08 | — | — |
| 2025-05-14 | -8.96 | -11.48 | — | — |
| 2025-03-13 | -10.64 | -0.44 | — | — |
| 2024-11-12 | -8.96 | -0.47 | — | — |
| 2024-08-12 | -13.17 | -0.54 | — | — |
| 2024-05-08 | -12.61 | -0.60 | — | — |
| 2024-03-13 | -12.88 | -0.54 | — | — |
| 2023-11-06 | -13.17 | -0.55 | — | — |
| 2023-08-14 | -10.92 | -16.25 | — | — |
| 2023-05-11 | -0.51 | -0.59 | — | — |
| 2023-03-17 | -0.44 | -0.52 | — | — |
| 2022-11-10 | -0.42 | -0.53 | — | — |
| 2022-08-08 | -0.46 | -0.48 | — | — |
| 2022-05-12 | -0.41 | -10.92 | — | — |
| 2022-03-21 | -0.22 | -0.90 | — | — |
| 2021-11-15 | -0.81 | -0.55 | — | 25.00M |
| 2021-08-16 | -154.90 | -2.56 | — | — |
| 2021-05-17 | -3.84 | -3.48 | — | — |
| 2021-03-16 | -2.12 | -3.40 | — | — |
| 2020-11-05 | -3.80 | -3.47 | — | — |
| 2020-08-05 | -4.00 | -4.27 | — | — |
| 2020-05-11 | -6.40 | -6.13 | — | — |
| 2020-03-13 | -14.40 | -12.00 | — | 750.00K |
| 2019-11-12 | -25.60 | -17.40 | — | — |
| 2019-08-09 | -24.00 | -24.16 | — | — |
| 2019-05-07 | -25.60 | -29.40 | — | — |
| 2019-02-27 | -29.60 | -24.16 | — | — |
| 2018-11-09 | -22.40 | -24.96 | — | — |
| 2018-08-15 | -27.20 | -26.08 | — | — |
| 2018-05-15 | -32.80 | -22.67 | — | — |
| 2018-03-09 | -30.40 | -22.00 | — | — |
| 2017-11-15 | -32.00 | -27.20 | — | — |
| 2017-08-10 | -37.60 | -24.80 | — | — |
| 2017-04-07 | -23.20 | -24.00 | — | — |
| 2016-09-01 | -30.40 | -29.60 | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-08 | Lu Qinglai | Other | 0 | — | — |
| 2026-03-23 | Yao Yun | Other | 0 | — | — |
| 2026-03-23 | SINO LION VENTURES Ltd | Other | 0 | — | — |
| 2026-03-23 | Dai Junyi | Other | 0 | — | — |
| 2026-03-23 | Lazar David E. | Sell | 196.80K | — | — |
| 2026-03-23 | Lazar David E. | Sell | 700.00K | — | — |
| 2026-02-26 | Jabbour Jerome D | Buy | 25.00K | $2.06 | 51.50K |
| 2026-02-26 | Jabbour Jerome D | Other | 0 | — | — |
| 2026-02-26 | McMurdo Matthew Charles | Other | 0 | — | — |
| 2026-02-11 | Meckler Jeffrey A | Buy | 12.14K | $1.75 | 21.24K |
| 2026-02-11 | Meckler Jeffrey A | Buy | 3.03K | $1.75 | 5.31K |
| 2026-02-11 | Meckler Jeffrey A | Buy | 1.52K | $1.75 | 2.66K |
| 2026-02-11 | Meckler Jeffrey A | Sell | 12.14K | $8.30 | 100.73K |
| 2026-02-11 | Meckler Jeffrey A | Sell | 3.03K | $47.60 | 144.37K |
| 2026-02-11 | Meckler Jeffrey A | Sell | 1.52K | $29.40 | 44.66K |
| 2026-01-20 | Ben-Tzvi Avraham | Buy | 25.00K | — | — |
| 2026-01-08 | NATAN DAVID | Other | 0 | — | — |
| 2026-01-07 | NATAN DAVID | Buy | 25.00K | $2.69 | 67.25K |
| 2025-12-23 | Ben-Tzvi Avraham | Buy | 25.00K | $1.95 | 48.75K |
| 2025-12-22 | Sassi Nir | Buy | 26.76K | $2.03 | 54.32K |
| 2025-12-22 | Meckler Jeffrey A | Buy | 216.62K | $2.03 | 439.73K |
| 2025-12-22 | Newman Michael James | Buy | 52.20K | $2.03 | 105.97K |
| 2025-12-22 | Linscott Walt Addison | Buy | 54.42K | $2.03 | 110.47K |
| 2025-12-22 | Lazar David E. | Other | 105.00M | — | — |
| 2025-12-22 | Lazar David E. | Other | 6.00M | — | — |
| 2025-12-22 | Lazar David E. | Other | 0 | — | — |
| 2025-12-22 | Ben-Tzvi Avraham | Other | 0 | — | — |
| 2025-07-27 | Meckler Jeffrey A | Buy | 12.14K | $8.30 | 100.76K |
| 2025-07-27 | Meckler Jeffrey A | Buy | 6.07K | $8.30 | 50.38K |
| 2025-06-10 | Karah Hila | Buy | 12.50K | $0.33 | 4.12K |
| 2025-06-10 | Martell Robert | Buy | 12.50K | $0.33 | 4.12K |
| 2025-06-10 | Hayes William B | Buy | 12.50K | $0.33 | 4.12K |
| 2025-06-10 | MADDALUNA ANTHONY J | Buy | 12.50K | $0.33 | 4.12K |
| 2025-06-10 | Pomerantz Roger | Buy | 30.00K | $0.33 | 9.90K |
| 2025-06-10 | Gilbert Mark John | Buy | 12.50K | $0.33 | 4.12K |
| 2024-11-25 | Meckler Jeffrey A | Buy | 42.55K | $1.18 | 50.00K |
| 2024-11-25 | Meckler Jeffrey A | Buy | 42.55K | $1.05 | 44.68K |
| 2024-10-09 | Newman Michael James | Buy | 75.00K | $1.10 | 82.88K |
| 2024-10-09 | Sassi Nir | Buy | 75.00K | $1.10 | 82.88K |
| 2024-10-09 | Waltzman Roger J. | Buy | 75.00K | $1.10 | 82.88K |
| 2024-10-09 | Linscott Walt Addison | Buy | 75.00K | $1.10 | 82.88K |
| 2024-10-09 | Meckler Jeffrey A | Buy | 75.00K | $1.10 | 82.88K |
| 2024-08-08 | Meckler Jeffrey A | Buy | 84.93K | $1.82 | 155.00K |
| 2024-08-08 | Meckler Jeffrey A | Buy | 84.93K | $1.70 | 144.38K |
| 2024-06-06 | Karah Hila | Buy | 12.50K | $2.63 | 32.88K |
| 2024-06-06 | Gilbert Mark John | Buy | 12.50K | $2.63 | 32.88K |
| 2024-06-06 | Pomerantz Roger | Buy | 30.00K | $2.63 | 78.90K |
| 2024-06-06 | MADDALUNA ANTHONY J | Buy | 12.50K | $2.63 | 32.88K |
| 2024-06-06 | Martell Robert | Buy | 12.50K | $2.63 | 32.88K |
| 2024-06-06 | Hayes William B | Buy | 12.50K | $2.63 | 32.88K |
| 2024-01-22 | Linscott Walt Addison | Buy | 75.00K | $1.74 | 130.50K |
| 2024-01-22 | Waltzman Roger J. | Buy | 75.00K | $1.74 | 130.50K |
| 2024-01-22 | Sassi Nir | Buy | 40.00K | $1.74 | 69.60K |
| 2024-01-22 | Meckler Jeffrey A | Buy | 100.00K | $1.74 | 174.00K |
| 2024-01-22 | Newman Michael James | Buy | 43.25K | $1.74 | 75.25K |
| 2023-08-14 | Anderson Glen R. | Buy | 23.93K | $2.34 | 56.01K |
| 2023-08-11 | Anderson Glen R. | Buy | 35.06K | $2.12 | 74.34K |
| 2023-08-10 | Anderson Glen R. | Buy | 44.35K | $1.94 | 86.05K |
| 2023-08-07 | Waltzman Roger J. | Buy | 90.00K | $1.85 | 166.50K |
| 2023-08-07 | Waltzman Roger J. | Other | 0 | — | — |
| 2023-05-25 | Karah Hila | Buy | 12.50K | $1.82 | 22.75K |
| 2023-05-25 | Hayes William B | Buy | 12.50K | $1.82 | 22.75K |
| 2023-05-25 | Gilbert Mark John | Buy | 12.50K | $1.82 | 22.75K |
| 2023-05-25 | Pomerantz Roger | Buy | 30.00K | $1.82 | 54.60K |
| 2023-05-25 | MADDALUNA ANTHONY J | Buy | 12.50K | $1.82 | 22.75K |
| 2023-02-13 | Martell Robert | Buy | 20.00K | $1.71 | 34.20K |
| 2023-02-13 | Martell Robert | Other | 0 | — | — |
| 2023-01-18 | Meckler Jeffrey A | Buy | 100.00K | — | — |
| 2023-01-18 | Linscott Walt Addison | Buy | 40.00K | — | — |
| 2023-01-18 | Sassi Nir | Buy | 40.00K | — | — |
| 2023-01-18 | Newman Michael James | Buy | 43.25K | — | — |
| 2022-12-01 | Litchev Boyan Vesselinov | Buy | 500 | $1.87 | 935 |
| 2022-11-22 | Litchev Boyan Vesselinov | Buy | 500 | $1.83 | 915 |
| 2022-11-21 | Meckler Jeffrey A | Buy | 9.60K | $1.90 | 18.24K |
| 2022-11-18 | Meckler Jeffrey A | Buy | 400 | $1.76 | 705 |
| 2022-09-30 | Karah Hila | Buy | 13.75K | — | — |
| 2022-09-30 | Pomerantz Roger | Buy | 81.00K | — | — |
| 2022-09-30 | Gilbert Mark John | Buy | 13.75K | — | — |
| 2022-09-30 | O'CALLAGHAN BRIAN | Buy | 13.75K | — | — |
| 2022-09-30 | MADDALUNA ANTHONY J | Buy | 13.75K | — | — |
| 2022-09-30 | Hayes William B | Buy | 13.75K | — | — |
| 2022-09-08 | Meckler Jeffrey A | Buy | 10.31K | $2.80 | 28.86K |
| 2022-09-07 | Linscott Walt Addison | Buy | 150 | $2.62 | 393 |
| 2022-09-06 | Meckler Jeffrey A | Buy | 8.63K | $2.57 | 22.18K |
| 2022-06-27 | Anderson Glen R. | Other | 0 | — | — |
| 2022-06-27 | Anderson Glen R. | Sell | 0 | — | — |
| 2022-06-06 | Meckler Jeffrey A | Buy | 19.73K | $2.63 | 51.88K |
| 2022-03-02 | Litchev Boyan Vesselinov | Buy | 50 | $4.09 | 205 |
| 2022-02-25 | Sassi Nir | Buy | 60.00K | $4.18 | 250.80K |
| 2022-02-01 | Litchev Boyan Vesselinov | Buy | 90.00K | $4.97 | 447.30K |
| 2022-02-01 | Newman Michael James | Sell | 14.13K | $5.00 | 70.69K |
| 2022-01-31 | Litchev Boyan Vesselinov | Buy | 100 | $4.65 | 465 |
| 2022-01-31 | Litchev Boyan Vesselinov | Other | 0 | — | — |
| 2022-01-31 | Newman Michael James | Sell | 5.87K | $5.00 | 29.35K |
| 2022-01-26 | Newman Michael James | Buy | 43.35K | $4.90 | 212.42K |
| 2022-01-26 | Meckler Jeffrey A | Buy | 200.00K | $4.90 | 980.00K |
| 2022-01-26 | Linscott Walt Addison | Buy | 45.85K | $4.90 | 224.67K |
| 2021-12-01 | Gilbert Mark John | Buy | 20.00K | $5.35 | 107.00K |
| 2021-11-29 | Gilbert Mark John | Other | 0 | — | — |
| 2021-11-18 | Meckler Jeffrey A | Buy | 11.19K | $5.82 | 65.11K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 9, holders +3 vs prior quarter. Ownership 0.33%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| HRT FINANCIAL LP | 206.08K | 206.08K | New | 618.00K |
| GEODE CAPITAL MANAGEMENT, LLC | 56.47K | 29.46K | +109.09% | 169.41K |
| JANE STREET GROUP, LLC | 53.81K | 53.81K | New | 161.43K |
| VANGUARD CAPITAL MANAGEMENT LLC | 33.65K | 33.65K | New | 100.96K |
| VANGUARD FIDUCIARY TRUST CO | 13.97K | 13.97K | New | 41.90K |
| MILLENNIUM MANAGEMENT LLC | 11.59K | 11.59K | New | 34.76K |
| MORGAN STANLEY | 8.94K | 6.24K | +231.33% | 26.81K |
| UBS GROUP AG | 478 | 478 | New | 1.43K |
| SBI SECURITIES CO., LTD. | 17 | 0 | 0.00% | 51 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0 | -1.89K | -100.00% | 0 |
| CITADEL ADVISORS LLC | 0 | -39.02K | -100.00% | 0 |
Earnings and financials
Indaptus Therapeutics, Inc. (INDP) trades at $3.33, with a market cap of $377.10M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn